The vision of the Snowdome Foundation is to ensure every Australian blood cancer
patient has the best opportunity for a cure, and this starts with a correct diagnosis.
We collaborate with world-leading Australian blood cancer researchers, both at home and overseas,
to accelerate new therapies and bring next-generation treatments to patients, faster.
We are the leading not-for-profit organisation focused exclusively on raising funds to
support translational research and clinical trials that will accelerate new treatments
(and cures) to help Australian blood cancer patients live longer, better lives.
Enabled more than $66 million to be invested in blood cancer research since 2010.
71 research projects funded enabling over 101 research positions.
Over 6,500 subsidised genomic tests completed at the Wilson Centre for Blood Cancer Genomics.
Enabled thousands of patients to participate in over 120 clinical trials.
Latest News

Developing a new cellular immunotherapy for T-cell lymphoma
We are pleased to provide an update on a pioneering research project to develop a new cellular immunotherapy for T-cell lymphoma.
Read more
Making Hope Real: How a clinical trial changed a patient’s treatment trajectory
Clinical trials make hope real for Australian blood cancer patients by transforming cutting-edge scientific findings into tangible treatment options.
Read more
Applications are now open for the 2025 Cannon Family Travel Grants
The Snowdome Foundation is inviting applications for the 2025 Cannon Family Travel Grants.
Read more